Reference
Castellanos EH, et al. Overcoming Resistance Without the Risk of Reaction: Use of Afatinib and Panitumumab in Two Cases of Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer With T790M Mutations. Clinical Lung Cancer 16: e97-e99, No. 5, Sep 2015. Available from: URL: http://doi.org/10.1016/j.cllc.2015.02.005 - USA
Rights and permissions
About this article
Cite this article
Afatinib/cetuximab/panitumumab. Reactions Weekly 1572, 14 (2015). https://doi.org/10.1007/s40278-015-1039-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-1039-2